Hankyel Park

Array ( [id] => 6797013 [patent_doc_number] => 20030175887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Saturation mutagenesis in directed evolution' [patent_app_type] => new [patent_app_number] => 10/309587 [patent_app_country] => US [patent_app_date] => 2002-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 34712 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175887.pdf [firstpage_image] =>[orig_patent_app_number] => 10309587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1009273 [patent_doc_number] => 06900035 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-05-31 [patent_title] => 'Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins' [patent_app_type] => utility [patent_app_number] => 10/289760 [patent_app_country] => US [patent_app_date] => 2002-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16270 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/900/06900035.pdf [firstpage_image] =>[orig_patent_app_number] => 10289760 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1095641 [patent_doc_number] => 06821744 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-23 [patent_title] => 'Method, assay, and kit for quantifying HIV protease inhibitors' [patent_app_type] => B2 [patent_app_number] => 10/284040 [patent_app_country] => US [patent_app_date] => 2002-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8661 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/821/06821744.pdf [firstpage_image] =>[orig_patent_app_number] => 10284040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1088863 [patent_doc_number] => 06828105 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-12-07 [patent_title] => 'Antisense antiviral agent and method for treating ssRNA viral infection' [patent_app_type] => B2 [patent_app_number] => 10/272865 [patent_app_country] => US [patent_app_date] => 2002-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 24 [patent_no_of_words] => 14807 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/828/06828105.pdf [firstpage_image] =>[orig_patent_app_number] => 10272865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843162 [patent_doc_number] => 20030148509 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Retrovirus isolated from humans' [patent_app_type] => new [patent_app_number] => 10/272394 [patent_app_country] => US [patent_app_date] => 2002-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9984 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148509.pdf [firstpage_image] =>[orig_patent_app_number] => 10272394 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7634565 [patent_doc_number] => 06657055 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-12-02 [patent_title] => 'Induction of a Th1-like response in vitro' [patent_app_type] => B2 [patent_app_number] => 10/267311 [patent_app_country] => US [patent_app_date] => 2002-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 23301 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/657/06657055.pdf [firstpage_image] =>[orig_patent_app_number] => 10267311 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787206 [patent_doc_number] => 20030138445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'gp41 antigen' [patent_app_type] => new [patent_app_number] => 10/263103 [patent_app_country] => US [patent_app_date] => 2002-10-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10336 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138445.pdf [firstpage_image] =>[orig_patent_app_number] => 10263103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6856228 [patent_doc_number] => 20030129729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Novel methods for rescue of RNA viruses' [patent_app_type] => new [patent_app_number] => 10/261961 [patent_app_country] => US [patent_app_date] => 2002-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16090 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129729.pdf [firstpage_image] =>[orig_patent_app_number] => 10261961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6869453 [patent_doc_number] => 20030082142 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-01 [patent_title] => 'Replication incompetent herpes viruses for use in gene therapy' [patent_app_type] => new [patent_app_number] => 10/168796 [patent_app_country] => US [patent_app_date] => 2002-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11616 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20030082142.pdf [firstpage_image] =>[orig_patent_app_number] => 10168796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6847337 [patent_doc_number] => 20030166504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Therapeutic compositions and methods for treating viral infection' [patent_app_type] => new [patent_app_number] => 10/226629 [patent_app_country] => US [patent_app_date] => 2002-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19989 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166504.pdf [firstpage_image] =>[orig_patent_app_number] => 10226629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6711532 [patent_doc_number] => 20030171281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Antimicrobial cationic peptides and formulations thereof' [patent_app_type] => new [patent_app_number] => 10/225087 [patent_app_country] => US [patent_app_date] => 2002-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22483 [patent_no_of_claims] => 192 [patent_no_of_ind_claims] => 46 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171281.pdf [firstpage_image] =>[orig_patent_app_number] => 10225087 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6643030 [patent_doc_number] => 20030104009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Retrovirus isolated from mantle histiocytes in mantle cell lymphoma' [patent_app_type] => new [patent_app_number] => 10/222945 [patent_app_country] => US [patent_app_date] => 2002-08-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 26251 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20030104009.pdf [firstpage_image] =>[orig_patent_app_number] => 10222945 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7625618 [patent_doc_number] => 06723551 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-20 [patent_title] => 'Production of adeno-associated virus in insect cells' [patent_app_type] => B2 [patent_app_number] => 10/216870 [patent_app_country] => US [patent_app_date] => 2002-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 19494 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/723/06723551.pdf [firstpage_image] =>[orig_patent_app_number] => 10216870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6851532 [patent_doc_number] => 20030143735 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-31 [patent_title] => 'Cellular receptor for HIV-1 Vpr essential for G2/M phase transition of the cell cycle' [patent_app_type] => new [patent_app_number] => 10/208338 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11629 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20030143735.pdf [firstpage_image] =>[orig_patent_app_number] => 10208338 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1123135 [patent_doc_number] => 06794174 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-09-21 [patent_title] => 'Full-length infectious cDNA clones of tick borne flavivirus' [patent_app_type] => B2 [patent_app_number] => 10/207745 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 10 [patent_no_of_words] => 23368 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/794/06794174.pdf [firstpage_image] =>[orig_patent_app_number] => 10207745 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1205299 [patent_doc_number] => 06716623 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-04-06 [patent_title] => 'Compositions and methods for identifying antigens which elicit an immune response' [patent_app_type] => B2 [patent_app_number] => 10/201764 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 54 [patent_no_of_words] => 30954 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/716/06716623.pdf [firstpage_image] =>[orig_patent_app_number] => 10201764 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1216211 [patent_doc_number] => 06706523 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-16 [patent_title] => 'Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS' [patent_app_type] => B2 [patent_app_number] => 10/199024 [patent_app_country] => US [patent_app_date] => 2002-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 43 [patent_no_of_words] => 35377 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/706/06706523.pdf [firstpage_image] =>[orig_patent_app_number] => 10199024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1107272 [patent_doc_number] => 06808877 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-10-26 [patent_title] => 'Ligands for FPR class receptors that induce a host immune response to a pathogen or inhibit HIV infection' [patent_app_type] => B2 [patent_app_number] => 10/199228 [patent_app_country] => US [patent_app_date] => 2002-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 69 [patent_no_of_words] => 24765 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/808/06808877.pdf [firstpage_image] =>[orig_patent_app_number] => 10199228 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1104644 [patent_doc_number] => 06812025 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-02 [patent_title] => 'Two hybrid assay that detects HIV-1 reverse transcriptase dimerization' [patent_app_type] => B2 [patent_app_number] => 10/009433 [patent_app_country] => US [patent_app_date] => 2002-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 30771 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 101 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/812/06812025.pdf [firstpage_image] =>[orig_patent_app_number] => 10009433 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6855699 [patent_doc_number] => 20030129200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Method for the development of an HIV vaccine' [patent_app_type] => new [patent_app_number] => 10/140356 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12664 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129200.pdf [firstpage_image] =>[orig_patent_app_number] => 10140356 [rel_patent_id] =>[rel_patent_doc_number] =>)